OR WAIT null SECS Martinez discusses the bigger picture of mavacamten, highlighting its safety and efficacy as well as recent real-world trial data in patients with HCM. Real-world evidence continues to refine the clinical profile of mavacamten in obstruc... See more
Navigating Safety and REMS Programs in oHCM Care - Episode 5 Martinez and Harper describe a hub-and-spoke model for HCM care, follow-up cadence, and a structured “4-pillar” framework for longitudinal management, including imaging, biomarkers, and family-b... See more
Navigating Safety and REMS Programs in oHCM Care - Episode 4 Martinez and Harper outline practical workflows for initiating and titrating cardiac myosin inhibitors, emphasizing multidisciplinary team structure, telemedicine, and logistics around REMS and ... See more
Navigating Safety and REMS Programs in oHCM Care - Episode 6 Martinez and Harper review real-world REMS data on cardiac myosin inhibitors, refine approaches to safety monitoring, and question how frequently echocardiography is truly needed in stable oHCM ... See more
Navigating Safety and REMS Programs in oHCM Care - Episode 3 Martinez and Harper discuss the limits of current therapies, the role of septal reduction procedures versus cardiac myosin inhibitors, and the complexities of managing younger and childbearing-a... See more
